Reckoning the potential of CRISPR/Cas9 tech, NIH launches $190M genome editing research initiative
Francis Collins, the director of the National Institutes of Health CQ/Roll Call Getty
As the first human trial involving CRISPR comes into …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
